Ekawa Therapeutics, Inc.

Ekawa Therapeutics has translated insights in the neural circuits of consciousness into novel therapeutics which will allow anesthesiologists to treat anesthetic emergence as an active process - in other words, to wake patients up faster, especially after long surgeries and/or deep anesthesia. Our “Anesthetic Reversal Agents” (ARAs) will facilitate faster post-operative and ICU recovery from deep anesthesia, which benefits the patient in terms of medical care and the hospital and medical staff in allowing more efficient utilization of staff time and the surgical or ICU suite. Because of the anticipated positioning within the surgical process, ARAs have almost MedTech-like development timelines and costs but pharmaceutical-like market potential.